OvaScience, Inc. (OVAS) in Focus: Stock Surges 12.2% – Tale of the Tape

March 25, 2015 Technicals 0

Zacks

OvaScience, Inc. (OVAS) was a big mover last session, as the company saw its shares surge over 12% on the day. The move came on positive interim results for its treatment Augment, which energizes the eggs of infertile women during in-vitro fertilization. The news led to far more shares changing hands than in a normal session resulting in solid volume. This reverses the recent trend of the company, as the stock is now trading above the volatile price range of $41.50 to $47.66 in the past one-month time frame.

The company has seen two negative revisions in the past one week, while its Zacks Consensus Estimate moved lower over the same time frame, suggesting there may be trouble down the road. So make sure to keep an eye on this stock going forward to see if this recent move higher can last.

OvaScience currently carries a Zacks Rank #3 (Hold) while its Earnings ESP is 0.00%.

A better-ranked stock in the same industry is Acorda Therapeutics, Inc. (ACOR), sporting a Zacks Rank #1 (Strong Buy).

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

To read this article on Zacks.com click here.

Zacks Investment Research

Be the first to comment

Leave a Reply